Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
JAMA Dermatol ; 160(5): 564, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38568680

ABSTRACT

This case report describes Osler nodes and Janeway lesions on a man in his 70s.


Subject(s)
Endocarditis, Bacterial , Humans , Endocarditis, Bacterial/diagnosis , Endocarditis, Bacterial/microbiology , Male , Female
2.
JCO Oncol Pract ; 20(3): 323-327, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38127854

ABSTRACT

Patients with cancer or with a history of cancer often seek nutritional advice. In turn, cancer health care providers are often asked questions related to nutrition and cancer. Should I take high-dose vitamins or other high-dose supplements? Should I take a regular-dose vitamin or other regular-dose nutritional supplements? Will I experience weight loss during postoperative chemotherapy? What should be my weight goals during and after adjuvant therapy? In the setting of advanced cancer, what should I do to keep my appetite and weight up? This review attempts to provide data-driven answers to some of these commonly posed questions.


Subject(s)
Neoplasms , Vitamins , Humans , Vitamins/pharmacology , Vitamins/therapeutic use , Appetite , Minerals/therapeutic use , Dietary Supplements , Weight Gain , Neoplasms/complications , Neoplasms/drug therapy , Neoplasms/epidemiology
3.
Curr Opin Support Palliat Care ; 17(3): 168-171, 2023 09 01.
Article in English | MEDLINE | ID: mdl-37499060

ABSTRACT

PURPOSE OF REVIEW: Over the past year, loss of appetite in patients with cancer has continued to be an area of active investigation. This review provides an update of recently published findings. RECENT FINDINGS: Despite the emergence of new cancer therapeutic agents, this symptom of loss of appetite continues to trouble patients, and it continues to be associated with poor survival. Recent preclinical research promises to lead to newer approaches and newer, more effective palliative agents. Recent clinical research shows that agents such as olanzapine, anamorelin, and cannabis either do or might palliate this symptom. SUMMARY: Loss of appetite in patients with cancer remains an important area of clinical and research focus. Recent published data provide greater clarity with respect to how to palliate this symptom. Today, although clinicians have more options to palliate cancer-associated loss of appetite than ever before, questions remain unanswered about how to palliate this symptom optimally and how to improve the quality of life of patients who suffer from it.


Subject(s)
Appetite , Neoplasms , Humans , Quality of Life , Neoplasms/complications , Neoplasms/drug therapy , Physical Therapy Modalities , Palliative Care/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...